149 related articles for article (PubMed ID: 8188668)
1. Promotion of human platelet adhesion and aggregation by a synthetic, triple-helical "mini-collagen".
Rao GH; Fields CG; White JG; Fields GB
J Biol Chem; 1994 May; 269(19):13899-903. PubMed ID: 8188668
[TBL] [Abstract][Full Text] [Related]
2. Melanoma cell adhesion and spreading activities of a synthetic 124-residue triple-helical "mini-collagen".
Fields CG; Mickelson DJ; Drake SL; McCarthy JB; Fields GB
J Biol Chem; 1993 Jul; 268(19):14153-60. PubMed ID: 8314781
[TBL] [Abstract][Full Text] [Related]
3. Promotion of cell adhesion by single-stranded and triple-helical peptide models of basement membrane collagen alpha 1(IV)531-543. Evidence for conformationally dependent and conformationally independent type IV collagen cell adhesion sites.
Miles AJ; Skubitz AP; Furcht LT; Fields GB
J Biol Chem; 1994 Dec; 269(49):30939-45. PubMed ID: 7983028
[TBL] [Abstract][Full Text] [Related]
4. Integrin alpha 2 beta 1-independent activation of platelets by simple collagen-like peptides: collagen tertiary (triple-helical) and quaternary (polymeric) structures are sufficient alone for alpha 2 beta 1-independent platelet reactivity.
Morton LF; Hargreaves PG; Farndale RW; Young RD; Barnes MJ
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):337-44. PubMed ID: 7534064
[TBL] [Abstract][Full Text] [Related]
5. Promotion of fibroblast adhesion by triple-helical peptide models of type I collagen-derived sequences.
Grab B; Miles AJ; Furcht LT; Fields GB
J Biol Chem; 1996 May; 271(21):12234-40. PubMed ID: 8647820
[TBL] [Abstract][Full Text] [Related]
6. Simple collagen-like peptides support platelet adhesion under static but not under flow conditions: interaction via alpha2 beta1 and von Willebrand factor with specific sequences in native collagen is a requirement to resist shear forces.
Verkleij MW; Morton LF; Knight CG; de Groot PG; Barnes MJ; Sixma JJ
Blood; 1998 May; 91(10):3808-16. PubMed ID: 9573018
[TBL] [Abstract][Full Text] [Related]
7. [Thrombocyte adhesion and aggregation on surfaces coated with human type-I, -III, -IV and -V collagens].
Misselwitz F; Leĭtin VL; Domogatskiĭ SP; Merzlikina OV; Novikov ID
Biull Eksp Biol Med; 1984 Sep; 98(9):359-64. PubMed ID: 6487797
[TBL] [Abstract][Full Text] [Related]
8. Platelet-reactive sites in human collagens I and III: evidence for cell-recognition sites in collagen unrelated to RGD and like sequences.
Zijenah LS; Barnes MJ
Thromb Res; 1990 Aug; 59(3):553-66. PubMed ID: 2237827
[TBL] [Abstract][Full Text] [Related]
9. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
Romstedt K; Huzoor-Akbar
Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
[TBL] [Abstract][Full Text] [Related]
10. Collagen-mediated platelet aggregation. Effects of collagen modification involving the protein and carbohydrate moieties.
Puett D; Wasserman BK; Ford JD; Cunningham LW
J Clin Invest; 1973 Oct; 52(10):2495-506. PubMed ID: 4354000
[TBL] [Abstract][Full Text] [Related]
11. Multimerin 1 supports platelet function in vivo and binds to specific GPAGPOGPX motifs in fibrillar collagens that enhance platelet adhesion.
Leatherdale A; Parker D; Tasneem S; Wang Y; Bihan D; Bonna A; Hamaia SW; Gross PL; Ni H; Doble BW; Lillicrap D; Farndale RW; Hayward CPM
J Thromb Haemost; 2021 Feb; 19(2):547-561. PubMed ID: 33179420
[TBL] [Abstract][Full Text] [Related]
12. Potentiation by adrenaline of human platelet activation and the inhibition by the alpha-adrenergic antagonist nicergoline of platelet adhesion, secretion and aggregation.
Lanza F; Cazenave JP; Beretz A; Sutter-Bay A; Kretz JG; Kieny R
Agents Actions; 1986 Aug; 18(5-6):586-95. PubMed ID: 3020942
[TBL] [Abstract][Full Text] [Related]
13. Platelet-collagen interaction. The influence of native and modified collagen (Type I) on the aggregation of human platelets.
Balleisen L; Marx R; Kühn K
Haemostasis; 1976; 5(3):155-64. PubMed ID: 1002002
[TBL] [Abstract][Full Text] [Related]
14. Reevaluation of the role of the polar groups of collagen in the platelet-collagen interaction.
Chesney CM; Pifer DD; Crofford LJ; Huch KM
Am J Pathol; 1983 Aug; 112(2):200-6. PubMed ID: 6881287
[TBL] [Abstract][Full Text] [Related]
15. A synthetic peptide derived from the sequence of a type I collagen receptor inhibits type I collagen-mediated platelet aggregation.
Chiang TM; Kang AH
J Clin Invest; 1997 Oct; 100(8):2079-84. PubMed ID: 9329973
[TBL] [Abstract][Full Text] [Related]
16. The platelet reactivity of synthetic peptides based on the collagen III fragment alpha1(III)CB4. Evidence for an integrin alpha2beta1 recognition site involving residues 522-528 of the alpha1(III) collagen chain.
Morton LF; Peachey AR; Knight CG; Farndale RW; Barnes MJ
J Biol Chem; 1997 Apr; 272(17):11044-8. PubMed ID: 9110997
[TBL] [Abstract][Full Text] [Related]
17. Platelet-collagen adhesion enhances platelet aggregation induced by binding of VWF to platelets.
Laduca FM; Bell WR; Bettigole RE
Am J Physiol; 1987 Nov; 253(5 Pt 2):H1208-14. PubMed ID: 3500650
[TBL] [Abstract][Full Text] [Related]
18. Platelet-reactivity of isolated constituents of the blood vessel wall.
Barnes MJ; MacIntyre DE
Haemostasis; 1979; 8(3-5):158-70. PubMed ID: 389755
[TBL] [Abstract][Full Text] [Related]
19. Effects of prostacyclin analogue (carbacyclin) on the interaction of platelets with different collagen substrates. Inhibition of cAMP increase by collagens type I, III, and IV.
Mazurov AV; Misselwitz F; Hoffman U; Leytin VL; Repin VS
Prostaglandins; 1988 Jan; 35(1):51-65. PubMed ID: 2836888
[TBL] [Abstract][Full Text] [Related]
20. Platelet-reactive sites in collagens type I and type III. Evidence for separate adhesion and aggregatory sites.
Morton LF; Peachey AR; Barnes MJ
Biochem J; 1989 Feb; 258(1):157-63. PubMed ID: 2539100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
